Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 19 | 2024 | 1069 | 3.470 |
Why?
|
| Echocardiography, Three-Dimensional | 6 | 2024 | 58 | 2.640 |
Why?
|
| Heart Defects, Congenital | 9 | 2024 | 1805 | 1.530 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 366 | 1.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2024 | 241 | 0.830 |
Why?
|
| Feasibility Studies | 2 | 2024 | 756 | 0.770 |
Why?
|
| Heart Transplantation | 2 | 2020 | 854 | 0.750 |
Why?
|
| Atrial Function, Left | 1 | 2020 | 27 | 0.700 |
Why?
|
| Pediatrics | 4 | 2021 | 1142 | 0.680 |
Why?
|
| Frailty | 1 | 2020 | 97 | 0.610 |
Why?
|
| Heart Ventricles | 4 | 2022 | 767 | 0.570 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2016 | 19 | 0.550 |
Why?
|
| Sinus of Valsalva | 1 | 2016 | 36 | 0.540 |
Why?
|
| Patient Care Bundles | 1 | 2016 | 23 | 0.530 |
Why?
|
| Quality Improvement | 2 | 2024 | 621 | 0.520 |
Why?
|
| Stroke Volume | 3 | 2022 | 448 | 0.510 |
Why?
|
| Heart Diseases | 1 | 2020 | 482 | 0.510 |
Why?
|
| Image Enhancement | 1 | 2016 | 168 | 0.500 |
Why?
|
| Aortic Rupture | 1 | 2016 | 118 | 0.500 |
Why?
|
| Exercise | 1 | 2020 | 800 | 0.470 |
Why?
|
| Postoperative Care | 1 | 2016 | 292 | 0.470 |
Why?
|
| Aortic Aneurysm | 1 | 2016 | 224 | 0.450 |
Why?
|
| Reproducibility of Results | 7 | 2024 | 2824 | 0.410 |
Why?
|
| Pulmonary Valve Insufficiency | 2 | 2024 | 40 | 0.410 |
Why?
|
| Heart Failure | 2 | 2015 | 2125 | 0.410 |
Why?
|
| Pulmonary Valve | 2 | 2024 | 98 | 0.380 |
Why?
|
| Child | 14 | 2024 | 24170 | 0.360 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 481 | 0.360 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2016 | 1101 | 0.350 |
Why?
|
| Diastole | 3 | 2022 | 170 | 0.340 |
Why?
|
| Heart Valve Prosthesis | 2 | 2024 | 293 | 0.330 |
Why?
|
| Adolescent | 9 | 2024 | 19043 | 0.320 |
Why?
|
| Humans | 29 | 2024 | 122971 | 0.300 |
Why?
|
| Child, Preschool | 8 | 2024 | 13858 | 0.300 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2024 | 425 | 0.300 |
Why?
|
| Levocardia | 1 | 2007 | 3 | 0.290 |
Why?
|
| Case-Control Studies | 3 | 2020 | 3257 | 0.290 |
Why?
|
| Hydrops Fetalis | 1 | 2007 | 75 | 0.280 |
Why?
|
| Atrioventricular Block | 1 | 2007 | 39 | 0.280 |
Why?
|
| Ventricular Function, Left | 4 | 2022 | 500 | 0.270 |
Why?
|
| Systole | 2 | 2015 | 197 | 0.240 |
Why?
|
| Observer Variation | 2 | 2016 | 300 | 0.240 |
Why?
|
| Prosthesis Design | 2 | 2024 | 667 | 0.230 |
Why?
|
| Heart | 3 | 2023 | 725 | 0.230 |
Why?
|
| Prospective Studies | 5 | 2024 | 6020 | 0.220 |
Why?
|
| Cardiac Catheterization | 2 | 2024 | 634 | 0.210 |
Why?
|
| Marfan Syndrome | 1 | 2024 | 137 | 0.210 |
Why?
|
| Recovery of Function | 1 | 2024 | 437 | 0.200 |
Why?
|
| Infant | 7 | 2024 | 12355 | 0.200 |
Why?
|
| Heart Atria | 2 | 2020 | 310 | 0.190 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 2025 | 0.180 |
Why?
|
| Male | 10 | 2024 | 59957 | 0.180 |
Why?
|
| Sulfonamides | 1 | 2022 | 258 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 232 | 0.180 |
Why?
|
| Accelerometry | 1 | 2020 | 58 | 0.180 |
Why?
|
| Diagnostic Errors | 2 | 2024 | 320 | 0.180 |
Why?
|
| Atrial Appendage | 1 | 2020 | 42 | 0.170 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 73 | 0.170 |
Why?
|
| Infant, Newborn | 7 | 2022 | 8120 | 0.170 |
Why?
|
| Female | 11 | 2024 | 65361 | 0.160 |
Why?
|
| Reference Values | 2 | 2022 | 699 | 0.160 |
Why?
|
| Disease Progression | 1 | 2024 | 2029 | 0.150 |
Why?
|
| Missouri | 1 | 2016 | 36 | 0.140 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 93 | 0.140 |
Why?
|
| Boston | 1 | 2016 | 110 | 0.140 |
Why?
|
| Vascular Stiffness | 1 | 2016 | 75 | 0.130 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 78 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2015 | 757 | 0.110 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 213 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2015 | 584 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2015 | 1380 | 0.090 |
Why?
|
| Quality of Life | 1 | 2020 | 1921 | 0.090 |
Why?
|
| Phenotype | 1 | 2020 | 4222 | 0.090 |
Why?
|
| Myocardium | 1 | 2015 | 983 | 0.090 |
Why?
|
| Neoplasms | 1 | 2023 | 2751 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12083 | 0.080 |
Why?
|
| Pulmonary Surfactants | 1 | 2007 | 43 | 0.070 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2007 | 38 | 0.070 |
Why?
|
| Epoprostenol | 1 | 2007 | 67 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 2846 | 0.070 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2007 | 79 | 0.070 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2007 | 89 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2007 | 359 | 0.070 |
Why?
|
| Prognosis | 1 | 2015 | 4503 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 5025 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2015 | 3319 | 0.060 |
Why?
|
| Balloon Valvuloplasty | 1 | 2024 | 25 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2007 | 392 | 0.060 |
Why?
|
| Mitral Valve Prolapse | 1 | 2024 | 28 | 0.060 |
Why?
|
| Syndrome | 1 | 2007 | 1123 | 0.060 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2024 | 23 | 0.060 |
Why?
|
| United States | 3 | 2024 | 10564 | 0.060 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2024 | 146 | 0.060 |
Why?
|
| Europe | 1 | 2024 | 370 | 0.050 |
Why?
|
| Propylene Glycol | 1 | 2002 | 8 | 0.050 |
Why?
|
| Lorazepam | 1 | 2002 | 12 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2023 | 114 | 0.050 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 156 | 0.050 |
Why?
|
| Mitral Valve | 1 | 2024 | 247 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2007 | 907 | 0.050 |
Why?
|
| Data Collection | 1 | 2023 | 383 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2002 | 134 | 0.050 |
Why?
|
| Consensus | 1 | 2024 | 606 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2024 | 848 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2020 | 113 | 0.040 |
Why?
|
| Allied Health Personnel | 1 | 2021 | 74 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2022 | 374 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2020 | 177 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 779 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 4688 | 0.030 |
Why?
|
| Length of Stay | 1 | 2020 | 1281 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2024 | 15934 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 25885 | 0.030 |
Why?
|
| Pregnancy | 1 | 2007 | 7126 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 6216 | 0.030 |
Why?
|
| Adult | 2 | 2024 | 28944 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3524 | 0.030 |
Why?
|
| Young Adult | 1 | 2024 | 8830 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 9950 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2007 | 64 | 0.020 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 2007 | 9 | 0.020 |
Why?
|
| High-Frequency Ventilation | 1 | 2007 | 16 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2007 | 50 | 0.020 |
Why?
|
| Foramen Ovale, Patent | 1 | 2007 | 15 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2007 | 178 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 172 | 0.020 |
Why?
|
| Hypoxia | 1 | 2007 | 248 | 0.020 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2007 | 142 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2002 | 173 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2002 | 146 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 539 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 1006 | 0.010 |
Why?
|